home2023-05-10T10:55:26+02:00

biomarkers for more stability in life

our purpose:
precision
medicine

discovery_and_validation_of_microRNA_biomarkers

TAmiRNA is a biotech company specialized in the discovery and validation of microRNA biomarkers. Our mission is to provide validated diagnostic solutions to patients with serious aging-related illnesses. We aim to improve and prolong patient stability, health and quality of life with increasing age.

TAmiRNA - stability for live

our technology:
microRNA
signatures

mircoRNA_signatures

We are specialized in biomarker development using blood-circulating microRNAs – evolutionary conserved regulators of gene expression and cell/tissue function. We develop diagnostic algorithms (“signatures”) based on the logic combination of microRNA levels and clinical parameters.

TAmiRNA - stability for live

our focus:
age-associated
diseases

age_associated_diseases

TAmiRNA is actively involved in R&D projects in osteoporosis (OP), cardio-vascular disease (CVD), liver disease and aging. OP and CVD are multifactorial illnesses. Using microRNA signatures we aim to decode the contributing disease factors on a personalized level, and to use this knowledge for better diagnosis.

TAmiRNA - stability for live

biomarkers for more stability in life

our purpose:
precision
medicine

discovery_and_validation_of_microRNA_biomarkers

TamiRNA is a biotech company specialized in the discovery and validation of microRNA biomarkers. Our mission is to provide validated diagnostic solutions to patients with serious aging-related illnesses. We aim to improve and prolong patient stability, health and quality of life with increasing age.

our technology:
microRNA
signatures

mircoRNA_signatures

We are specialized in biomarker development using blood-circulating microRNAs – evolutionary conserved regulators of gene expression and cell/tissue function. We develop diagnostic algorithms (“signatures”) based on the logic combination of microRNA levels and clinical parameters.

our focus:
age-associated
diseases

TAmiRNA is actively involved in R&D projects in osteoporosis (OP), cardio-vascular disease (CVD), liver disease and aging. OP and CVD are multifactorial illnesses. Using microRNA signatures we aim to decode the contributing disease factors on a personalized level, and to use this knowledge for better diagnosis.

our products

TAmiRNA - stability for live
TAmiRNA - stability for live
TAmiRNA - stability for live

our products

TAmiRNA - stability for live
TAmiRNA - stability for live
TAmiRNA - stability for live

our services

microRNA services

services

Serum, plasma, urine, saliva, exosomes, cells, and tissues … We provide solutions for your biomarker discovery and validation needs in any biological matrix.

TAmiRNA - the power of microRNA biomarkers

Kit services

Send us your samples to obtain results for osteomiR®, thrombomiR® or toxomiR® biomarkers by taking advantage of our in-house services.

TAmiRNA - the power of microRNA biomarkers
Click_here_for_your_personalized_microRNA_service_offer

our services

microRNA services

services

Serum, plasma, urine, saliva, exosomes, cells, and tissues … We provide solutions for your biomarker discovery and validation needs.

TAmiRNA - the power of microRNA biomarkers

One-Stop-Shop

Obtain results for osteomiR, thrombomiR,and toxomiR biomarkers in your samples by taking advantage of our inhouseservices.

TAmiRNA - the power of microRNA biomarkers
TAmiRNA - stability for live

latest news

TAmiRNA at the GSEV 2024 Scientific Conference

By |September 27th, 2024|Categories: biomarker, biomarkers, exosomes, extracellular vesicle, Illumina NewSeq2000, microRNAs, miND, NGS, small RNA-sequencing|Tags: , , , , , , , |

We are thrilled to announce that TAmiRNA will contribute a poster at the upcoming German Society for Extracellular Vesicles (GSEV) Autumn Meeting 2024, presenting our recent advancements in the [...]

Eager to lern more about neuron-derived extracellular vesicles as predictive biomarkers

By |September 18th, 2024|Categories: biomarker, biomarkers, exosomes, microRNA services, microRNAs, miND spike ins, NGS, sequencing, smallRNA|Tags: , , , , , , |

A new study from the University of Trieste explores the potential of microRNA (miRNA) profiles in neuron-derived extracellular vesicles (NDEVs) as predictive biomarkers for adverse drug reactions (ADRs) in [...]

Comments Off on Eager to lern more about neuron-derived extracellular vesicles as predictive biomarkers

TAmiRNA at ASEV/CzeSEV meeting

By |September 11th, 2024|Categories: biomarker, biomarkers, Evercyte, EVscale, microRNAs, NGS, Phoenestra, small RNA-sequencing|Tags: , , , , , , , |

TAmiRNA, Evercyte and Phoenestra, three leading biotech companies, will present their cutting-edge work in for production and characterization of clinical-grade extracellular vesicles (EVs) at the upcoming shared Annual Meeting [...]

Comments Off on TAmiRNA at ASEV/CzeSEV meeting

TAmiRNA at the GSEV 2024 Scientific Conference

By |September 27th, 2024|Categories: biomarker, biomarkers, exosomes, extracellular vesicle, Illumina NewSeq2000, microRNAs, miND, NGS, small RNA-sequencing|Tags: , , , , , , , |

We are thrilled to announce that TAmiRNA will contribute a poster at the upcoming German Society for Extracellular Vesicles (GSEV) Autumn Meeting 2024, presenting our recent advancements in the biodistribution of extracellular [...]

Eager to lern more about neuron-derived extracellular vesicles as predictive biomarkers

By |September 18th, 2024|Categories: biomarker, biomarkers, exosomes, microRNA services, microRNAs, miND spike ins, NGS, sequencing, smallRNA|Tags: , , , , , , |

A new study from the University of Trieste explores the potential of microRNA (miRNA) profiles in neuron-derived extracellular vesicles (NDEVs) as predictive biomarkers for adverse drug reactions (ADRs) in children receiving ketamine. [...]

Comments Off on Eager to lern more about neuron-derived extracellular vesicles as predictive biomarkers

TAmiRNA at ASEV/CzeSEV meeting

By |September 11th, 2024|Categories: biomarker, biomarkers, Evercyte, EVscale, microRNAs, NGS, Phoenestra, small RNA-sequencing|Tags: , , , , , , , |

TAmiRNA, Evercyte and Phoenestra, three leading biotech companies, will present their cutting-edge work in for production and characterization of clinical-grade extracellular vesicles (EVs) at the upcoming shared Annual Meeting of the Austrian [...]

Comments Off on TAmiRNA at ASEV/CzeSEV meeting
Go to Top